NewslettersHepatic Cell NewsEchosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASHBy Danielle Corrigan - June 24, 20220145Echosens and Novo Nordisk A/S announced a partnership to advance early diagnosis of non-alcoholic steatohepatitis (NASH) and increase awareness of the disease among patients, healthcare providers, and other stakeholders.[Echosens]Press Release